In one 30-second spot, Wilson explains that while GLP-1s reduce "food noise" (persistent thoughts about eating), that noise can return after treatment ends
Safety depends on the patient, dose, pharmacy quality, sterility, potency, and clinical monitoring
This once daily 3.0 mg subcutaneous injection demonstrated meaningful weight losses in clinical trials with optimal results occurring when combined with reduced calorie diet and increased physical activity
A thorough evaluation of your medical history, current medications, weight loss goals, and individual risk factors will guide the decision toward the medication most likely to provide safe, effective results for your specific situation
Ignoring this trend risks obsolescence, while embracing it offers a pathway to innovation and growth